FB
FibroBiologics, Inc. Common Stock (FBLG)
NASDAQ·Healthcare·Biotechnology
$0.95
-3.02%
Mkt Cap $3.00M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$180.00
Range $180.00 – $180.00
Implied Upside
+18847.4%
Consensus $180.00 vs current $0.95